U.S. Physical Therapy (NYSE:USPH) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research note issued on Saturday. The firm presently has a $82.00 price objective on the stock. Zacks Investment Research‘s price objective indicates a potential upside of 10.96% from the stock’s current price.

According to Zacks, “U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics, with over 500 Clinics in 42 States. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh’s clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company’s growth, are structured like the de novo partnerships, with significant ownership retained by founders. “

A number of other brokerages have also issued reports on USPH. Barrington Research lowered shares of U.S. Physical Therapy from an “outperform” rating to a “market perform” rating in a research report on Friday, November 3rd. Cantor Fitzgerald reaffirmed a “buy” rating and set a $72.00 target price on shares of U.S. Physical Therapy in a research report on Tuesday, September 26th. Sidoti upgraded shares of U.S. Physical Therapy from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $62.00 to $74.00 in a research note on Friday, September 8th. Finally, BidaskClub upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, October 25th. Three equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company currently has an average rating of “Buy” and a consensus target price of $72.60.

Shares of U.S. Physical Therapy (NYSE USPH) traded up $0.25 during mid-day trading on Friday, reaching $73.90. 32,371 shares of the company were exchanged, compared to its average volume of 56,773. U.S. Physical Therapy has a fifty-two week low of $56.50 and a fifty-two week high of $78.00. The company has a market capitalization of $926.60, a price-to-earnings ratio of 44.52, a P/E/G ratio of 2.72 and a beta of 1.09. The company has a debt-to-equity ratio of 0.30, a current ratio of 2.04 and a quick ratio of 2.04.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Thursday, November 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.52 by ($0.04). U.S. Physical Therapy had a return on equity of 13.37% and a net margin of 5.29%. The company had revenue of $103.03 million for the quarter, compared to the consensus estimate of $102.69 million. equities analysts anticipate that U.S. Physical Therapy will post 2.07 EPS for the current fiscal year.

In other U.S. Physical Therapy news, Director Mark J. Brookner sold 2,625 shares of U.S. Physical Therapy stock in a transaction on Wednesday, December 27th. The shares were sold at an average price of $71.23, for a total transaction of $186,978.75. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Clayton Trier sold 4,250 shares of U.S. Physical Therapy stock in a transaction on Tuesday, December 12th. The stock was sold at an average price of $71.97, for a total transaction of $305,872.50. The disclosure for this sale can be found here. Insiders have sold 31,875 shares of company stock worth $2,173,623 in the last quarter. Corporate insiders own 3.10% of the company’s stock.

Several large investors have recently modified their holdings of USPH. Aberdeen Asset Management PLC UK boosted its stake in shares of U.S. Physical Therapy by 13.4% in the 2nd quarter. Aberdeen Asset Management PLC UK now owns 705,007 shares of the company’s stock valued at $42,582,000 after purchasing an additional 83,253 shares in the last quarter. Renaissance Technologies LLC boosted its stake in shares of U.S. Physical Therapy by 10.4% in the 2nd quarter. Renaissance Technologies LLC now owns 668,074 shares of the company’s stock valued at $40,352,000 after purchasing an additional 63,074 shares in the last quarter. Wells Fargo & Company MN boosted its stake in shares of U.S. Physical Therapy by 62.1% in the 3rd quarter. Wells Fargo & Company MN now owns 73,542 shares of the company’s stock valued at $4,519,000 after purchasing an additional 28,170 shares in the last quarter. OxFORD Asset Management LLP boosted its stake in shares of U.S. Physical Therapy by 491.6% in the 3rd quarter. OxFORD Asset Management LLP now owns 33,231 shares of the company’s stock valued at $2,041,000 after purchasing an additional 27,614 shares in the last quarter. Finally, King Luther Capital Management Corp boosted its stake in shares of U.S. Physical Therapy by 61.3% in the 3rd quarter. King Luther Capital Management Corp now owns 57,695 shares of the company’s stock valued at $3,545,000 after purchasing an additional 21,935 shares in the last quarter. Institutional investors own 94.12% of the company’s stock.

TRADEMARK VIOLATION NOTICE: This story was originally posted by American Banking News and is the sole property of of American Banking News. If you are accessing this story on another domain, it was illegally copied and reposted in violation of U.S. and international trademark & copyright law. The correct version of this story can be read at https://www.americanbankingnews.com/2018/01/06/u-s-physical-therapy-usph-raised-to-buy-at-zacks-investment-research.html.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.